Literature DB >> 29964337

MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation.

Chuanqing Wu1, Xiaojie Zhu1, Kaixiong Tao1, Weizhen Liu1, Tuo Ruan1, Wenze Wan1, Chun Zhang2, Weikang Zhang1.   

Abstract

The long non-coding RNA MALAT1 has been proved to promote the cell proliferation, drug resistance, invasion, and metastasis of colorectal cancer (CRC) in vitro and in vivo by regulating the expression of various oncogenes and their protein products. Our previous work discovered that the expression of the mRNA-decapping enzymes 1a (DCP1A) is upregulated in CRCs. However, the relationships between MALAT1 and DCP1A in the development of CRC and the underlying mechanisms are still unclear. In this study, we investigated the molecular mechanisms by which MALAT1 and DCP1A may be linked to contribute to the malignancies of CRCs. We found that DCP1A is a direct target molecule of MALAT1. Moreover, by screening the downstream genes of MALAT1, we noticed that microRNA 203(miR203), an oncogene suppressor in numerous cancers, is inversely correlated to both MALAT1 and DCP1A expressions. Following MALAT1 knockdown, we observed overexpression of miR203 accompanied with DCP1A downregulation to a level that reversed the promoted cell proliferation, invasion, and migration in vitro and in vivo, which could be restored by miR203 knockdown or DCP1A overexpression. These results proposed a new molecular mechanism of MALAT-miR203-DCP1A axis which is involved with the development and contributes to the malignancy of colorectal cancers.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  DCP1A; MALAT-1; colorectal cancer; long non-coding RNA; miR203

Mesh:

Substances:

Year:  2018        PMID: 29964337     DOI: 10.1002/mc.22868

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  17 in total

1.  Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer.

Authors:  Florian Oehme; Stefan Krahl; Balazs Gyorffy; Benjamin Muessle; Venkatesh Rao; Helena Greif; Nicole Ziegler; Kuailu Lin; May-Linn Thepkaysone; Heike Polster; Torsten Tonn; Martin Schneider; Juergen Weitz; Franziska Baenke; Christoph Kahlert
Journal:  RNA Biol       Date:  2019-07-07       Impact factor: 4.652

Review 2.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

3.  Long non-coding RNA ATB is associated with metastases and promotes cell invasion in colorectal cancer via sponging miR-141-3p.

Authors:  Xianming Liu; Cunchuan Wang
Journal:  Exp Ther Med       Date:  2020-10-27       Impact factor: 2.447

Review 4.  The Role of Long Non-Coding RNAs in Thyroid Cancer.

Authors:  Xuejiao Peng; Kun Zhang; Li Ma; Junfeng Xu; Weiqin Chang
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

5.  Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer.

Authors:  Kexin Zhao; Si Jin; Bo Wei; Shiqiong Cao; Zhifan Xiong
Journal:  Cancer Manag Res       Date:  2018-11-23       Impact factor: 3.989

6.  MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5.

Authors:  Haimin Zhang; Wei Li; Wenyu Gu; Yang Yan; Xudong Yao; Junhua Zheng
Journal:  Cell Prolif       Date:  2019-06-27       Impact factor: 6.831

7.  Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles.

Authors:  Khaled AbouAitah; Heba A Hassan; Anna Swiderska-Sroda; Lamiaa Gohar; Olfat G Shaker; Jacek Wojnarowicz; Agnieszka Opalinska; Julita Smalc-Koziorowska; Stanislaw Gierlotka; Witold Lojkowski
Journal:  Cancers (Basel)       Date:  2020-01-07       Impact factor: 6.639

8.  Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis.

Authors:  Chunyan Luan; Yongzhu Li; Zhigang Liu; Cunxin Zhao
Journal:  Onco Targets Ther       Date:  2020-04-30       Impact factor: 4.147

9.  Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.

Authors:  Daojun Hu; Boke Zhang; Miao Yu; Wenjie Shi; Li Zhang
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

10.  Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.

Authors:  Meng He; Juxin Shen; Chunyi Zhang; Yefeng Chen; Weisi Wang; Kelong Tao
Journal:  Med Sci Monit       Date:  2020-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.